I think the nearest catalyst is P2 data for the non-core AVIR drug BTA074. My gut is to wait until after this binary to consider a position in VXRT given that AVIR sought to go forward with the merger despite ample cash. So, why should I have high expectations for this binary event? We'll see how that thought process plays out.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.